共 50 条
CD95/Fas stoichiometry in future precision medicine
被引:0
|作者:
Sica, Mauricio
[1
]
Roussel, Murielle
[2
,3
]
Legembre, Patrick
[2
]
机构:
[1] Inst Balseiro UNCuyo, Bariloche Atom Ctr, CONICET, Dept Fis Med GAANS CNEA, Ave Bustillo 9500, San Carlos De Bariloche, Rio Negro, Argentina
[2] Univ Limoges, UMR CNRS 7276, INSERM U1262, CRIBL, 2 Rue Marcland, Limoges, France
[3] CHU Dupuytren, Clin Hematol & Cellular Therapy Dept, Limoges, France
关键词:
OSTEOCLAST DIFFERENTIATION FACTOR;
FAS LIGAND;
SIGNALING PATHWAY;
DECOY RECEPTOR;
DEATH DOMAIN;
TNF;
COMPLEX;
CELLS;
OSTEOPROTEGERIN;
IDENTIFICATION;
D O I:
10.1038/s41418-025-01493-9
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
CD95, also known as Fas, belongs to the tumor necrosis factor (TNF) receptor superfamily. The main biological function of this receptor is to orchestrate and control the immune response since mutations in CD95 or deregulation of its downstream signaling pathways lead to auto-immunity and inflammation. Interestingly, more than twenty years ago, pioneer studies highlighted that like TNFR1, TRAILR1 or CD40, CD95 pre-associates at the plasma membrane in a ligand-independent fashion. This self-association occurs through a domain designated pre-ligand assembly domain or PLAD. Although the disruption of this pre-association prevents CD95 signaling, no drugs targeting this region have been generated because many questions remain on the stoichiometry and conformation of this receptor. Despite more than 40.000 publications, no crystal structure of CD95 alone or in combination with its ligand, CD95L, exists. Based on other TNFR members, we herein discuss the predicted conformation of CD95 at the plasma membrane and how these putative structures might account for the induction of the cell signaling pathways.
引用
收藏
页数:8
相关论文